Phil Robinson presenting Steve Williams talk on a clinically relevant rapid sample preparation method and prognostic signature identification for HPV-Related Oropharyngeal Squamous Cell Carcinoma #HUPO2022#ProCan
At an update event held five years and one month after the ProCan® laboratory first opened, the ProCan team outlined major progress towards their goal of analysing cancers rapidly to help cancer clinicians make the best treatment decision for individual patients. 1/
Congratulations to CMRI's Prof Phil Robinson who is part of an international team that recently won a significant grant supporting their studies of brain development.
https://t.co/eO10ZSlmII
More great news for CMRI researchers this week! Congratulations to Professor Ian Alexander and Professor Robyn Jamieson who were successful in the Luminesce Alliance Innovation in Paediatric Precision Medicine Seed Funding Round. https://t.co/kIy1WCCm4K
CMRI Professor Phil Robinson and University of Newcastle Professor Adam McCluskey are part of an Australian team that discovered a way to target cancer cells that “hide’’ from chemotherapy. Read more in Nature Communications: https://t.co/Dmg2xjdmqg
I'm very pleased to announce our publication "Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk paediatric cancer" online today in @NatureMedicine https://t.co/1iwP4nqBlo Here's a tweetorial of the main findings 1/22
First high-throughput paper from #Procan, the ACRF Center for Proteomics of Cancer. Data acquired on 6 instruments over 6 months, showing new ways to normalisze and impute. Kudos to the team. @CMRI_AUS @NatureComms @rebecca_poulos https://t.co/1F4K1nTM8m
JUST RELEASED: #COVID19 has changed our lives in ways very few of us would have guessed, including at our medical research institutes. We wanted to show the world the speed &breadth of change that happened at our institutes in Australia so we created an animation to do just that.
A senior CMRI researcher has described the discovery of a new way to treat cancer in patients who don’t respond to current treatments as having “tremendous potential to save lives’’. Read more https://t.co/139PVZe0va
Opportunity for a postdoc based on EMBL-EBI in collaboration with Stanford Univ. Are you interested?
https://t.co/QnqB5cQm4p. The project would be shared between my team & M. Snyder’s team. If interested, please contact me asap. Deadline for applications is March 8th. Please RT.
Ten travel grants are up for grabs for Australian life science PhD students! Grants of up to $2,000 are available to help support students to attend an @embl course or conference.
Applications close in two weeks!⌛